title: [What are the tools for post-occupational follow-up, how should they be performed and what are their performance, limits and benefit/risk ratio? Chest X-Ray and CT scan].
abstract: Chest radiography and computed tomography (CT) are the two radiological techniques used for the follow-up of people exposed to asbestos. Since the last conference of consensus (1999), the scientific literature has primarily covered high-resolution CT and high-resolution volume CT (HR-VCT). We consider in turn the contribution of digital thoracic radiography, recommendations for the performance of HR-VCT to ensure the quality of examination while controlling the delivered radiation dose, and the need to refer to the "CT atlas of benign diseases related to asbestos exposure", published by a group of French experts in 2007, for interpretation. The results of the published studies concerning radiography or CT are then reviewed. We note the great interobserver variability in the recognition of pleural plaques and asbestosis, indicating the need for adequate training of radiologists, and the importance of defining standardized, quantified criteria for CT abnormalities. The very low agreement between thoracic and general radiologists must be taken into account. The reading of CT scans in cases of occupational exposure to asbestos should be entrusted to thoracic radiologists or to general radiologists having validated specific training. A double interpretation of CT could be considered in medicosocial requests. CT is more sensitive than chest radiography in the detection of bronchial carcinoma but generates a great number of false positive results (96 to 99%). No scientific data are available to assess the role of imaging by either CT or chest radiography in the early detection of mesothelioma.
authors: Université J-Fourrier, BP 53, 38041 Grenoble cedex 9, France. gferretti@chu-grenoble.fr
authors: G
authors: G
authors: Ferretti
mesh_terms: D001195:Asbestosis / Q000000981:diagnostic imaging* / Q000209:etiology / Q000473:pathology; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003625:Data Collection; D005500:Follow-Up Studies; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D008403:Mass Screening; D015588:Observer Variation; D010994:Pleura / Q000000981:diagnostic imaging / Q000473:pathology; D011159:Population Surveillance / Q000379:methods*; D017410:Practice Guidelines as Topic; D013902:Radiography, Thoracic / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D015203:Reproducibility of Results; D012107:Research Design; D012142:Respiratory Tract Neoplasms / Q000000981:diagnostic imaging / Q000209:etiology; D012179:Retirement; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data